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Abstract
The aim of this study was to investigate the practical utility of endocervicoscopy and targeted biopsy in high-risk human
papilloma virus–positive women with abnormal squamous cells on cervical cytology and unsatisfactory colposcopy with
nonvisible squamocolumnar junction. Seventy-seven high-risk human papilloma virus–positive patients with abnormal cervical
cytology for squamous cells bearing type 3 transformation zone were enrolled. Endoscopic examination of the endocervical
epithelium, with office-based continuous-flow hysteroscopy after application of acetic acid 5%, followed by targeted biopsies
and consequent large loop excision of the transformation zone was carried out. Sensitivity, specificity, positive predictive value
and negative predictive value of endocervicoscopy, and orientated biopsy were confronted with the results of large loop
excision of the transformation zone (referral test). The sensitivity and specificity of endocervicoscopy and orientated biopsy
for low-grade cervical intraepithelial neoplasia were 53% and 81%, respectively, while the sensitivity and specificity for high-
grade cervical intraepithelial neoplasia were 64% and 47%, respectively. The positive predictive value for low-grade cervical
intraepithelial neoplasia was 64% and for high-grade cervical intraepithelial neoplasia was 88%. The negative predictive value for
low-grade cervical intraepithelial neoplasia was 87% and for high-grade cervical intraepithelial neoplasia was 41%. Endo-
cervicoscopy is a safe, office-based technique. It is a reliable method to detect the transformation zone in patients with type 3
transformation zone and unsatisfactory colposcopy. It potentially allows target biopsy of the transformation zone but presents
a relatively low specificity/negative predictive value to predict high-grade cervical intraepithelial neoplasia, thus negative biopsy
results should be interpreted with caution.
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Introduction
Colposcopy is a relatively precise technique and, in expert
hands, is a formidable tool in evaluating cervical preneoplastic
disease. Colposcopy was first introduced in early 1925 by Hans
Hinselmann, and Walter Schiller proposed a precursor of Pap
smear in 1928. Despite the continuous changes in techniques
and devices, the main aim of colposcopy remains the detection
of precancerous lesions.1,2
Colposcopy associated with cervical cytology and the human
papilloma virus (HPV) test are the most effective examinations
to detect cervical intraepithelial neoplasia (CIN), and together
they have contributed to the dramatic decrease in the incidence
of cervical squamous carcinoma.3-10 However, the false positive
and false negative results of cytology are well known.11-18
Not all women present a visible squamocolumnar junction
(SCJ) suitable for colposcopic evaluation of the transformation
zone (TZ). The discrepancy between a positive high-risk HPV
test and a borderline cytology in women with nonvisible TZ
constitutes a therapeutic dilemma and may lead to unnecessary
conization which, especially in the childbearing age, is an over-
treatment with a considerable burden for patients and
community.
Endocervicoscopy is a relatively new procedure proposed
for the evaluation of endocervical epithelium. This technique
combines the classic hysteroscopic equipment with the colpo-
scopic classification system.19,20 The aim of this study was to
investigate the accuracy of endocervicoscopy with orientated
biopsy to detect CIN in high-risk HPV–positive women with
abnormal squamous cells on cervical cytology, nonvisible SCJ,
and unsatisfactory colposcopy (type 3 TZ).
Patients and Methods
Among 435 patients who underwent colposcopy, 77 women,
bearing a type 3 TZ, were enrolled. All patients underwent
endocervicoscopy with orientated punch biopsy and conse-
quent large loop excision of the transformation zone (LLETZ)
according to the guideline of the European Federation for Col-
poscopy in the management of abnormal cervical cytology.21
In all cases, SCJ was visualized and, regardless of the endo-
cervicoscopic findings, all biopsies were performed on TZ.
Inclusion criteria were a positive high-risk HPV test, ade-
quate cervical cytology consistent with squamous dyskaryosis
(low and high grade) or abnormal squamous cells, a type 3 TZ,
and an intact LLETZ, including the TZ, with no CIN on endo-
cervical, ectocervical, and deep/lateral margins. Exclusion cri-
teria were a negative high-risk HPV test, inadequate cervical
cytology, type 1 and 2 TZ, abnormal cytology consistent or
suspicious for glandular lesion, and patients who underwent
conization. The LLETZs with positive margins and/or with no
TZ included, fragmented LLETZs and LLETZs which showed
important diathermy artifacts, not suitable for a precise evalua-
tion of margins, were also excluded from the study.
Normal endocervicoscopy consisted of the absence of acet-
oreactive areas and abnormal vessels. Abnormal endocervico-
scopic findings consisted of acetowhite areas, abnormal
vessels, cuffed crypt (gland) openings, and erosion. Irregular
border, inner border sign, ridge sign, and rapid appearance of
acetowhitening, which are part of colposcopic findings, were
not assessable in endocervicoscopy procedure.
Cervical cytology was carried out by fluid-based, thin-layer
ThinPrep (Cytyc, Boxborough, Massachusetts) as previously
reported.22 Endocervicoscopy with biopsy was performed
according to the procedure described by Bifulco et al.19
The study was conducted according to the World Medical
Association Declaration of Helsinki. The aim of this study was
to ameliorate the diagnostic service; therefore, no institutional
review board and/or ethics committee approval from San Carlo
Hospital, Rome, Italy, was necessary. Patients provided oral
informed consent, which was inserted into the medical charts.
Statistical Analysis
Statistical analysis was performed with SPSS software package
V.22 (SPSS, Inc, Chicago, Illinois). Demographic and clinical
characteristics were summarized by standard descriptive
summaries.
Pearson chi-square test was used to assess the association
(contingency) between the results provided by the diagnostic
tests here considered. Finally, to describe the performance of
punch biopsy during endocervicoscopy with respect to LLETZ,
sensitivity, specificity, positive predictive value (PPV), and
negative predictive value (NPV) were calculated.
Results
The study was performed between 2011 and 2015. Seventy-
seven patients met the inclusion criteria and were eligible for
study. The mean age of patients was 41.1+ 9.6 years (median
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42 years, range 20-67 years). Cytology showed low-grade dys-
karyosis in 28 (36.4%), high-grade dyskaryosis in 28 (36.4%),
borderline squamous cells in 8 (10.4%), and borderline/suspi-
cious high-grade squamous cells in 13 (16.9%) patients.
Endocervicoscopic findings were normal in 11 (14.3%) and
abnormal in 66 (85.7%) patients. Endocervical biopsy showed
negative results in 13 (16.9%), low-grade CIN in 14 (18.2%),
and high-grade CIN in 50 (64.9%) patients (Table 1).
Considering cytology findings and endocervicoscopy (P ¼
0.79) of 28 patients with low-grade dyskaryosis on cytology, 4
patients showed normal, while 24 patients showed abnormal
endocervicoscopy results. Of the 28 patients with high-grade
dyskaryosis on cytology, 3 patients had normal, while 25 had
abnormal endocervicoscopy results. Endocervicoscopy was
normal in 1 of 8 women with borderline squamous cells, while
7 women showed abnormal findings. Among 13 patients with
borderline/suspicious high-grade cytology, 3 had normal endo-
cervicoscopy results, while in 10 the findings were abnormal.
Considering endocervicoscopy and endocervical biopsy
results, among 13 patients with a normal biopsy results, 4 had
normal and 9 had an abnormal endocervicoscopy result. Three
of 14 women showing low-grade CIN (Figure 1) had normal
endocervicoscopy, while 11 showed abnormal results.
Among 50 patients presenting high-grade CIN on biopsy
(Figure 2), 4 had normal endocervicoscopy and 46 showed
abnormal results. Although the number of patients is too low,
there was a statistically significant association between LLETZ
and endocervicoscopy results (P ¼ .016).
The comparison between endocervicoscopy and LLETZ
results showed that among 17 patients presenting low-grade
CIN, 5 had normal and 12 presented abnormal endocervico-
scopy results. Among 59 patients with high-grade CIN, 5 had a
normal and 54 showed abnormal findings. One patient with
microinvasive squamous cell carcinoma (SCC) showed normal
endocervicoscopy (Table 2).
When the results of endocervical biopsy were compared
with the results of LLETZ, a statistically significant association
(P ¼ .003) was found: 2 of 13 patients with normal biopsy
showed low-grade CIN on LLETZ, while 11 patients showed
high-grade CIN. Of the 14 patients with low-grade CIN on
biopsy, 9 showed the same results on LLETZ, while 5 patients
showed high-grade CIN.
Table 1. Clinical and Cyto-Histopathological Characteristics
of Patients.a
Characteristics Results, N ¼ 77
Age, years 41.1 (9.6)
Cytology
LGSDYS 28 (36.4)
HGSDYS 28 (36.4)
BSC 8 (10.4)
BSC/HG 13 (16.9)
EC
Normal 11 (14.3)
Abnormal 66 (85.7)
ECB
Normal 13 (16.9)
LGCIN 14 (18.2)
HGCIN 50 (64.9)
LLETZ
Normal 0 (0)
LGCIN 17 (22.1)
HGCIN 59 (76.6)
SCC 1 (1.3)
Abbreviations: BSC, borderline squamous cells (atypical squamous cells of
uncertain significance [ASCUS]); BSC/HG, borderline squamous cells/high-
grade (atypical squamous cells of uncertain significance/high-grade [ASC-
HG]); EC, endocervicoscopy; ECB, endocervical biopsy; HGCIN, high-
grade cervical intraepithelial neoplasia; HGSDYS, high-grade squamous dys-
karyosis (high-grade intraepithelial lesion [HGSIL]); LGCIN, low-grade cer-
vical intraepithelial neoplasia; LGSDYS, low-grade squamous dyskaryosis
(low-grade intraepithelial lesion [LGSIL]); LLETZ, loop excision of the trans-
formation zone; SCC, squamous cell carcinoma.
aResults are expressed as means (standard deviations) or as frequency
(percentage).
Figure 1. Endocervicoscopic biopsy of low-grade CIN.
Figure 2. Endocervicoscopic biopsy of high-grade CIN.
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Among 50 patients showing high-grade CIN on biopsy, the
diagnosis was confirmed on LLETZ in 43 patients; 6 women
showed low-grade CIN and 1 patient showed SCC (Table 3).
Table 4 reports the sensitivity, specificity, PPV, and NPV of
endocervicoscopic biopsy with respect to LLETZ. The sensi-
tivity and specificity for low-grade CIN were 53% and 81%,
respectively. The sensitivity and specificity for high-grade CIN
were 64% and 47%, respectively. The PPV for low-grade CIN
was 64% and 88% for high-grade CIN. The NPV for low-grade
CIN was 87% and 41% for high-grade CIN.
Discussion
In the present study, we show a statistically significant associa-
tion between cervical cytology results and endocervicoscopic
findings. Only 13 of 77 patients with abnormal squamous cells
on cytology showed normal endocervicoscopy. These data sug-
gest that endocervicoscopy is a reliable method to detect the TZ
in patients with a type 3 TZ and potentially allows target biopsy.
It is worth mentioning that endocervicoscopy presents some
limits similar to classic colposcopy. The presence of acetowhite
endocervical areas does not necessarily mean abnormality
because these could represent a normal physiological phenom-
enon such as immature squamous metaplasia. Conversely, the
absence of acetowhite areas does not rule out cervical dysplasia.
The sensitivity (true positive rate) of endocervicoscopy with
biopsy, as a diagnostic tool, is moderate/high (64%) for detect-
ing high-grade CIN and moderate (53%) for detecting low-
grade CIN. The specificity (true negative rate) is low/moderate
(47%) for high-grade CIN and high (81%) for low-grade CIN.
Seven patients with normal endocervicoscopy showed either
low-grade CIN (3 patients; 27.2%) or high-grade CIN
(4 patients; 36.3%) on direct biopsy. This means that 63.6%
of patients with normal endocervicoscopic findings presented
CIN on biopsy. When the results of biopsy were compared with
LLETZ, relatively worrisome data emerged. According to our
findings, while endocervicoscopy and biopsy showed a high
NPV (87%) for low-grade CIN, the NPV for high-grade CIN
was relatively low (41%).
This means that the probability that a patient without high-
grade CIN on biopsy did not have this disease in LLETZ (NPV)
was 41%. Endocervicoscopy and biopsy show a high PPV for
high-grade CIN and a relatively high PPV for low-grade CIN.
The probability that the diagnosis of CIN was confirmed on
LLETZ (PPV) was 88% for high-grade CIN and 64% for low-
grade CIN. However, the possibility that the entire lesion was
removed by biopsy prior to LLETZ cannot be ruled out.
It is noteworthy that the data regarding SCC are unreliable
because only 1 case was detected. Nevertheless, the reasons
for failure to detect abnormal endocervicoscopic features of
SCC, even in 1 case, need to be investigated more in depth.
Since endocervicoscopy, as classic colposcopy, is an
operator-dependent technology, human factors as a source
of error cannot be ruled out. Nevertheless, it should be empha-
sized that the patient had a microinvasive SCC (FIGO stage
1A1) which can be misdiagnosed even in classic colposcopy.
Table 3. Biopsy Results by LLETZ Expressed as Frequency
(Percentage).
LLETZ
P Valuea
CIN 1,
N ¼ 17
CIN 2-3,
N ¼ 59
SCC,
N ¼ 1
Endocervical biopsy Normal 2 (11.8) 11 (18.6) 0 .003
LGCIN 9 (52.9) 5 (8.5) 0
HGCIN 6 (35.3) 43 (72.9) 1
Abbreviations: CIN, cervical intraepithelial neoplasia; HGCIN, high-grade cer-
vical intraepithelial neoplasia; LGCIN, low-grade cervical intraepithelial neo-
plasia; LLETZ, loop excision of the transformation zone; SCC, squamous cell
carcinoma.
aP value refers to chi-square test.
Table 4. Sensitivity, Specificity, PPV, and NPV of Endocervical
Biopsy Considering LLETZ as the Gold Standard.
LLETZ results
LGCIN (%) HGCIN (%)
Sensitivity 53 64
Specificity 81 47
PPV 64 88
NPV 87 41
Abbreviations: HGCIN, high-grade cervical intraepithelial neoplasia; LGCIN,
low-grade cervical intraepithelial neoplasia; LLETZ, loop excision of the
transformation zone; NPV, negative predictive value; PPV, positive predictive
value.
Table 2. Endocervicoscopy Results by PAP, Biopsy (ECB), and
LLETZ.a
Endocervicoscopy
P ValuebNormal, N ¼ 11 Abnormal, N ¼ 66
Cytology
LGSDYS 4 (36.3) 24 (36.3) .79
HGSDYS 3 (27.2) 25 (37.9)
BSC 1 (9) 7 (10.6)
BSC/HG 3 (27.2) 10 (15.2)
ECB
Negative 4 (36.3) 9 (13.6) .096
LGCIN 3 (27.2) 11 (16.7)
HGCIN 4 (36.3) 46 (69.7)
LLETZ
LGCIN 5 (45.5) 12 (18.2) .016
HGCIN 5 (45.5) 54 (81.8)
SCC 1 (9) 0
Abbreviations: BSC, borderline squamous cells; BSC/HG, borderline squa-
mous cells/high grade; ECB, endocervical biopsy; HGCIN, high-grade cervical
intraepithelial neoplasia; HGSDYS, high-grade squamous dyskaryosis;
LGCIN, low-grade cervical intraepithelial neoplasia; LGSDYS, low-grade
squamous dyskaryosis; LLETZ, large loop excision of the transformation zone;
PAP, Papanicolaou test; SCC, squamous cell carcinoma.
aResults are expressed as frequency (percentage).
bP value refers to chi-square test.
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Furthermore, in case of previous damage to cervical mucosa
(laser treatment, cold coagulation, cryotherapy), reparative
re-epithelization might hide the undermining neoplastic pro-
cess. The patient included in this study referred that 3 years
before conization she had had outpatient treatment with no
histological analysis; however, we were unable to find the
details of treatment.
Management of patients with a type 3 TZ largely depends on
cervical cytological/histological results. An unsatisfactory col-
poscopy following high-grade CIN warrants a diagnostic/thera-
peutic LLETZ. If colposcopic biopsy is normal and cervical
cytology is less severe than high-grade CIN, then repeating
cytology at 6 and 12months, HPV testing at 1 year, or a cytology
and colposcopy at 1 year are all acceptable strategies.23
Cervical conization, in many instances, may not reveal a
preneoplastic condition. Although LLETZ is widely regarded
as minor surgery and can be performed on an outpatient basis, it
is well known that this procedure carries significant morbidity
and complications include cervical stenosis, bleeding, prema-
ture rupture of the membranes, preterm delivery, low birth
weight, and an increased risk of caesarean delivery.24,25
However, with regard to the preterm birth, relatively recent
data show that women with a history of LEEZ have similar risk
of preterm birth when compared with women with prior dys-
plasia but no cervical excision.26 Endocervical curettage could
represent an alternative to endocervicoscopy. However, curet-
tage is an uncomfortable, relatively invasive and blind proce-
dure, which does not allow determination of the exact
topography of endocervical lesions or the possibility to carry
out target biopsy. Additionally, it has been shown that endo-
cervical curettage, with respect to endocervicoscopy, misses a
non-negligible part of endocervical abnormalities.19 Endocer-
vicoscopy is an office-based technique with no anesthesia and/
or analgesia requirements where instrumentation for traditional
hysteroscopy is used. However, a few issues should be
addressed. Endocervical curettage is a well-accepted and dif-
fuse method, and the aim of our study was not to compare
endocervicoscopy with biopsy and endocervical curettage
because there are extremely limited data on endocervicoscopy
in the literature. Our attempt was to design a study, which could
focus on an innovative method.
Our data do not confirm the good performance reported in
the previous study.19 Although the number of patients in our
study was relatively small, our findings showed that endocer-
vicoscopic biopsy presents a low specificity/NPV to identify
high-grade CIN and negative biopsy results should be inter-
preted with caution. This finding represents the weakness and
limit of endocervicoscopic biopsy in daily clinical practice.
Theoretically, underestimation of low-grade CIN might not
constitute real harm for the patient while underdiagnosed
high-grade CIN, due to its potential malignancy, cannot be
underestimated. A high-grade CIN may hide an underlying
microinvasive/invasive SCC. It is worth mentioning that since
no patient with a clinical history of conization was included in
this study, unsatisfactory colposcopy might be due to atrophy
or unknown anatomy abnormality of TZ (Figure 3).
Future studies with a large number of patients are warranted
in order to analyze the causes of pitfalls in the diagnostic
capacity of endocervicoscopy in patients with type 3 TZ and
unsatisfactory colposcopy.
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Figure 3. The summary of the results. This table summarize the relationship between the results of cytology, histology (biopsy and LLETZ) with
endocervicoscopy findings.
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